Aesthetics Sales Representative

Company DescriptionEvoCyte is a leading distribution company specializing in South Korean aesthetic solutions, recognized for their cutting-edge innovation and significant investments in research and development. As the official and exclusive distributor in the UK and Ireland for industry-renowned manufacturers like Primoris International ( a leading stem-cell and exosomes aesthetic company), and Theraderm (a South Korean expert in cosmeceuticals and dermatological solutions for over 20 years), EvoCyte empowers clients with world-class aesthetic products that deliver exceptional results.Role DescriptionThis is a full-time hybrid role for an Aesthetics Sales Representative based in the London Area, United Kingdom, with opportunities for partial remote work. The primary role of the Aesthetics Sales Representative involves building and maintaining strong relationships with clients in the aesthetics industry. Day-to-day tasks include identifying and pursuing sales opportunities, providing product demonstrations, educating clients about EvoCyte's portfolio, and achieving sales targets. The role also includes attending industry events and maintaining up-to-date knowledge of the advanced products EvoCyte distributes.Qualifications2 years of aesthetics or pharmaceutical sales experience with a focus on business development, client relationship management, and negotiation skills.Knowledge of or interest in regenerative aesthetics, cosmeceuticals, skincare, or medical devices, with a willingness to continuously improve product-related expertise.Strong communication and presentation skills to effectively engage clients and deliver product education.Self-motivated and organized, with the ability to work independently and within a hybrid work structure.Experience in managing accounts in the UK or knowledge of the regional market.Prior experience in the aesthetic, medical, or skincare industries is mandatory.Valid driver's license and willingness to travel within designated regions as required.

Created: 2026-02-07